Practice
Featured experience
Big Lots chapter 11 filing, $707.5 million DIP financing and stalking horse APA
We are advising Big Lots in connection with the restructuring
VF $1.5 billion sale of Supreme to EssilorLuxottica
We are advising VF on the transaction
Truist $15.5 billion sale of remaining stake in Truist Insurance to investor group
We are advising Truist on the transaction
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
InVue sale to ASSA ABLOY
We advised InVue on the transaction
Ferrero Group acquisition of Power Crunch
We are advising Ferrero on the transaction
Norwegian Cruise Line $1.8 billion senior notes offering
The high-yield notes are due 2032
SMFG $3.2 billion senior notes offering
We advised SMFG on its SEC-registered offering of TLAC notes
Rokt $300 million merger with mParticle
We are advising Rokt on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition